Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Affiliations

• ¹ Department of Medicine II (Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Diseases), University Cancer Center Leipzig (UCCL), University Medical Center, Leipzig, Germany.
• ² Department of Pathology, Centro Hospitalar Universitário de São João (CHUSJ), Porto; Faculty of Medicine, University of Porto (FMUP), Porto; Instituto de Investigação e Inovação em Saúde (i3S)/Institute of Molecular Pathology and Immunology, University of Porto (Ipatimup), Porto, Portugal.
• ³ Department of Medical Oncology, Comprehensive Cancer Center, Università Vita-Salute, IRCCS Ospedale San Raffaele, Milan, Italy.
• ⁴ Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
• ⁵ Department of Radiation Oncology, University Hospital Leuven, Leuven, Belgium.
• ⁶ University of Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille;; CNRS, UMR9020, Lille; Inserm, U1277, Lille; CHU Lille, Department of Digestive and Oncological Surgery, Lille, France.
• ⁷ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
• ⁸ Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.